FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to composition containing at least two active ingredients, opioid analgesic, and opioid agonist in non-swelling diffusive matrix. Releasing characteristics are defined by matrix made of ethylcellulose and at least one fatty alcohol. Also disclosed is pharmaceutical preparation containing 10-150 mg of oxycodone and 1-50 mg of naloxone in standard dose.
EFFECT: composition of long storage time with prolonged invariant and independent releasing of substances.
17 cl, 14 dwg, 16 ex, 19 tbl
Authors
Dates
2007-04-20—Published
2003-04-04—Filed